ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of aclidinium/formoterol (AB/FF) 400/12 μg twice daily on lung hyperinflation, exercise capacity, and physical activity in patients with moderate-to-severe COPD. Patients received AB/...

Descripción completa

Detalles Bibliográficos
Autores principales: Watz, Henrik, Troosters, Thierry, Beeh, Kai M, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Notari, Massimo, Zapata, Antonio, Jarreta, Diana, Garcia Gil, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574699/
https://www.ncbi.nlm.nih.gov/pubmed/28883722
http://dx.doi.org/10.2147/COPD.S143488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574699/
https://www.ncbi.nlm.nih.gov/pubmed/28883722
http://dx.doi.org/10.2147/COPD.S143488

Ejemplares similares